q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

Forty-Five (45) New Generic Equivalents Added to Medicare Part D in March & April 2016

Category: Monthly Formulary changes
Published: May, 02 2016 04:05:26
< Previous
Next >
March 2016 saw the addition of 42 new generic equivalents (NDCs) and in the April 2016 Medicare Part D plan formulary data (or drug lists) updates an additional three (3) generic equivalents (NDCs) were added.  The three April additions are highlighted in the chart below in bold.  As a note, the May 2016 Medicare Part D plan formulary data included no new drug codes and only minor additions and deletions from plan formularies.

The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

The following 45 manufacturer / drug / strength / packaging combinations (NDCs) were added to one or more Medicare Part D formularies in the recent updates. You can click on the NDC or Drug Name below to go to our Q1Medicare.com DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Generic Drug Name Brand-Name Drug
00093526018 ALMOTRIPTAN MALATE 6.25 MG TAB [Axert]
00093526119 ALMOTRIPTAN MALATE 12.5 MG TAB [Axert]
13811069230 ARIPIPRAZOLE ODT 10 MG TABLET [Abilify]
13811069330 ARIPIPRAZOLE ODT 15 MG TABLET [Abilify]
00054057521 ASPIRIN-DIPYRIDAM ER 25-200 MG [Sodium Edecrin]
00378395009 ATORVASTATIN 10 MG TABLET [Lipitor]
00378395109 ATORVASTATIN 20 MG TABLET [Lipitor]
00378395209 ATORVASTATIN 40 MG TABLET [Lipitor]
00378395309 ATORVASTATIN 80 MG TABLET [Lipitor]
00378695501 BEXAROTENE 75 MG CAPSULE [Targretin]
68180029706 DULOXETINE HCL DR 40 MG CAPSULE [Cymbalta]
00115143810 DUTASTERIDE 0.5 MG CAPSULE [Avodart]
10370028009 DUTASTERIDE-TAMSULOSIN 0.5-0.4 [JALYN]
42023015701 ETHACRYNATE SODIUM 50 MG VIAL [Sodium Edecrin]
00115152210 FENOFIBRATE 40 MG TABLET [LIPOFEN]
00115152310 FENOFIBRATE 120 MG TABLET [LIPOFEN]
69973010590 FENOFIBRIC ACID 105 MG TABLET [TRILIPIX]
53489067707 FENOFIBRIC ACID 35 MG TABLET [TRILIPIX]
00781537031 FLUVASTATIN ER 80 MG TABLET [Lescol]
00143972001 LEVOFLOXACIN-D5W 750 MG/150 ML [LEVAQUIN]
39822035001 LINCOMYCIN HCL 600 MG/2 ML VL [LINCOCIN]
59762130801 LINEZOLID 100 MG/5 ML SUSP [Zyvox]
00591390087 MEMANTINE 5-10 MG TITRATION PK [Namenda Titration]
00527194313 MEMANTINE HCL 2 MG/ML SOLUTION [Namenda]
55111059660 MEMANTINE HCL 5 MG TABLET [Namenda]
00591387544 MEMANTINE HCL 10 MG TABLET [Namenda]
64720022810 MOLINDONE HCL 5 MG TABLET [Moban]
64720022910 MOLINDONE HCL 10 MG TABLET [Moban]
64720023010 MOLINDONE HCL 25 MG TABLET [Moban]
63323085074 MOXIFLOXACIN 400 MG/250 ML BAG [Avelox]
00378397893 PALIPERIDONE ER 1.5 MG TABLET [INVEGA]
00378397993 PALIPERIDONE ER 3 MG TABLET [INVEGA]
00378398093 PALIPERIDONE ER 6 MG TABLET [INVEGA]
00378398193 PALIPERIDONE ER 9 MG TABLET [INVEGA]
66993006602 PHENOXYBENZAMINE HCL 10 MG CAP [Dibenzyline]
49884034701 PIMOZIDE 1 MG TABLET [Orap]
49884034801 PIMOZIDE 2 MG TABLET [Orap]
68180049001 REPAGLINIDE-METFORMIN 1-500 MG [PrandiMet]
68180049101 REPAGLINIDE-METFORMIN 2-500 MG [PrandiMet]
47335066868 RISEDRONATE SODIUM 35 MG TABLET [Actonel]
68180019309 TELMISARTAN-HCTZ 40-12.5 MG TB [Micardis HCT]
00603592716 TELMISARTAN-HCTZ 80-12.5 MG TB [Micardis HCT]
00603592816 TELMISARTAN-HCTZ 80-25 MG TAB [Micardis HCT]
68682042112 TETRABENAZINE 12.5 MG TABLET [XENAZINE]
68682042225 TETRABENAZINE 25 MG TABLET [XENAZINE]

What Could the Addition of New Generic Drugs Mean to You?

  • You may be able to save money by switching from the brand-name drug to its generic equivalent – with your prescriber’s approval and a new prescription.  Please note, you will need to look carefully at coverage costs as we have found that many 2016 generics are being offered on the same tier as their brand-name equivalent or the generics do not have a significantly lower retail price.  For example, the brand-name Targretin (75 mg) may have a retail cost of around $7,464 as a Tier 5 drug (30% co-insurance) and the same plan may now cover the generic equivalent BEXAROTENE 75 MG also as a Tier 5 drug (30% co-insurance) with a retail price of around $6,607.  You can click here to see how your Medicare drug plan is covering these medication.
  • Your brand name drug may no longer be available if a generic is now available.  From past experience, we expect to find that many Medicare Part D plans may discontinue coverage of brand-name drugs over the next few months when generic drug equivalents are introduced.  For example, the brand-name drug PrandiMet has already been removed from all 2016 Medicare Part D formularies and replaced with the generic REPAGLINIDE-METFORMIN.  If you have received notice from your Medicare Part D plan that your brand-name medication will be dropped, you should speak with your prescriber to determine if you can take the generic equivalent or if you will need to ask your plan for a formulary exception to continue coverage for the brand-name drug.  You can click for a chart showing the trends in formulary coverage for some of the most popular Medicare drugs and their generic equivalents.
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at Q1Medicare.com/FormularyBrowser or compare how any medication is covered on all Medicare plans in your service area using our Q1Medicare.com/DrugFinder.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting your Medicare plan
Star Ratings & plan quality
Annual Medicare plan changes
Enrollment topics
Late Enrollment Penalty (LEP)
Your Formulary (Drug List)
Monthly Formulary changes
Your Medicare plan coverage
Pharmacies & Providers
Changing Medicare plans
Special Enrollment Periods (SEPs)
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and high costs
Out-of-Pocket: TrOOP, RxMOOP, and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for higher incomes
Medicare Advantage plans (MAPD)
Medicare Supplements - Medigap
Medicare plan providers
General Medicare Part D (PDP)
General Medicare
Diabetes and diabetic coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.